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The radial artery is increasingly adopted as the primary access site for cardiac catheterization due to patient preference, lower bleeding rates, cost effectiveness and reduced risk of mortality in high risk patient groups. Concerns have been expressed that operators/centers have become increasingly unfamiliar with trans-femoral access (TFA). The aim of this study is to assess whether a change in access site practice towards transradial access (TRA) nationally has led to worse outcomes in percutaneous coronary intervention (PCI) procedures performed through the TFA approach.
Methods and Results
Using the BCIS (British Cardiovascular Intervention Society) database, a retrospective analysis of 235,250 TFA PCI procedures was undertaken in all 92 centers in England and Wales between 2007 and 2013. Recent femoral proportion (RFP) and recent femoral volume (RFV) were determined and in-hospital vascular complications and 30-day mortality were evaluated.  After case-mix-adjustment, no independent association was observed between 30-day mortality for cases undertaken through the TFA and center femoral proportion, the risk-adjusted odds ratio for RFP was non-significant (OR=0.99;95%CI=0.97-1.02;p=0.472 per 0.1 increase in proportion), similarly RFV (per 100 procedures) was not found to be significant (OR=1.00;95%CI=0.98-1.01;p=0.869). The in-hospital vascular complication rate was 1.0% and this outcome was not significantly associated with RFP after risk-adjustment, (OR=0.97;95%CI=0.94-1.00;p=0.060 per 0.1 increase in proportion).
Conclusions
The outcome gains achieved by the national adoption of radial access is not associated with a loss of femoral proficiency, and centers should be encouraged to continue to adopt radial access as the default access site for PCI wherever possible in line with current best evidence.





	The radial artery has been increasingly adopted as the primary access site for cardiac catheterization in Europe and Asia and the United States. ADDIN EN.CITE 1-4 Transradial access (TRA) is associated with a reduced risk of mortality in some randomized controlled trials ADDIN EN.CITE 5,6 and in large unselected patient populations in national registries ADDIN EN.CITE 3,4,7-9 in high-risk patients undergoing percutaneous coronary intervention (PCI). Consequently, the European Society of Cardiology (ESC) Guidelines have recommended radial access as the preferred access site choice with a class IA indication for PCI cases undertaken for patients presenting with non ST-segment elevation myocardial infarction (NSTEMI). ADDIN EN.CITE 10 However, even in high volume radial centers, there are situations where even experienced radial operators will perform PCI using a transfemoral approach (TFA), such as in patients presenting with hemodynamic instability or cardiogenic shock where the radial artery is not palpable, ADDIN EN.CITE 8 in elderly individuals where anatomical variations preclude a radial approach, ADDIN EN.CITE 11 or in patients where radial puncture has failed to secure access. Thus even in high volume centers where the radial approach is the default strategy, a femoral approach is required in between 5-10% of cases. ADDIN EN.CITE 12,13
	The relationship between experience and outcome has been reported for a number of surgical procedures including PCI and forms the basis of the volume outcome relationship. Specifically increased volume is associated with reduced complications rates and improved clinical outcomes. ADDIN EN.CITE 14,15 Volume outcomes relationships have been reported in relation to TRA outcomes; for example the RIVAL study reported that the primary outcome of death, myocardial infarction, stroke, or non-CABG related major bleeding was significantly lower in the TRA arm in the subgroup of high volume radial centers, but not in intermediate- or low-volume radial centers, and there was no significant interaction by individual operator radial volume. ADDIN EN.CITE 16,17 Similarly, the recent MATRIX RCT demonstrated a particularly pronounced benefit of TRA access in centers that performed >80% radial PCI. ADDIN EN.CITE 5 With the increasing dominance of trans-radial access (TRA) for PCI, concerns have been expressed that as operators/centers become increasingly unfamiliar with TFA, outcomes in procedures where femoral access is necessary might become compromised ADDIN EN.CITE 18,19 (recently termed the Campeau radial paradox). ADDIN EN.CITE 19 However, it is unclear from the existing literature whether this is a real access-related effect or represents the impact of case mix on outcomes.20
	In the United Kingdom, TRA has become the default access site used for PCI increasing from 14% in 2005 to over 75% in 2014. ADDIN EN.CITE 21 This change provides an opportunity to study whether TFA outcomes have been compromised by such a large scale change in national access site practice.
	Here we study outcomes in PCI cases undertaken through the femoral approach over time, in centers that have transitioned to become predominantly TRA default centers compared to those that have remained predominantly femoral.  The key objectives were to assess whether a change in access site practice towards TRA at a center level has led to worse TFA outcomes and to determine whether improved clinical outcomes achieved by the national adoption of radial access ADDIN EN.CITE 21 are attenuated by a loss of femoral proficiency.

METHODS
	This retrospective cohort study evaluated outcomes for femoral procedures recorded in the UK national PCI database. We studied this from an individual center perspective, and used measures of recent center femoral experience to investigate how case-mix and 30-day mortality (both unadjusted and adjusted) are associated with TRA uptake. 

The British Cardiovascular Intervention Society Database
	The British Cardiovascular Intervention Society (BCIS) collects data on all PCI procedures in the UK. ADDIN EN.CITE 4,22-24 The data collection is coordinated by the National Institute of Cardiovascular Outcomes Research (NICOR) (http://www.ucl.ac.uk/nicor/) via a centralized electronic database. Case ascertainment is high, in 2011 this dataset collected information on 99.4% of all PCI procedures performed in NHS Hospitals in England and Wales.
	The BCIS-NICOR database comprises 113 variables, including clinical variables, procedural parameters and patient outcomes. Mortality tracking is undertaken by the Medical Research Information Service (MRIS) using patients’ NHS number that provides a unique identifier for any person registered with the NHS in England and Wales. It is a legal requirement for all deaths in the UK to be registered, providing extremely reliable tracked data on mortality events during post procedure follow up.

Cohort selection and definitions
	All adult, femoral-only procedures undertaken in the NHS in England and Wales recorded in the BCIS registry from 1 January 2007 to 31 December 2013 (7 years) were considered in the primary analysis. Data were organized by year for analysis purposes. Three measures of recent center experience were calculated for each procedure; the total volume of procedures undertaken by the center in the 12 months preceding the procedure date, regardless of access site (Recent Total Volume, RTV); the volume of femoral procedures undertaken by the operating center in the 12 months preceding the procedure date (Recent Femoral Volume, RFV); and this number as a proportion of total procedures in the preceding 12 months (Recent Femoral Proportion, RFP=RFV/RTV). In order to derive these rolling measures a 12-month lead-in period was required and so the first 12 months of data for each center were used for derivation of experience measures and were necessarily excluded in the primary analysis. Where possible data from prior to 1 January 2007 contributed to this. We also excluded cases where multiple access sites were used or access site choice was unclear, where indication, sex or age were missing, and where patients were recorded as younger than 18 or over 100 years old (Figure 1). 
	The proportion of TFA cases in each center in 2013 (femoral proportion (2013)) was used to stratify centers into low (<33·3%), medium (33·3-66·7%) and high (>66·7%) femoral proportion groups. For centers inactive or closed during 2013 the last available 12 months of data were used to define femoral proportion. Low femoral proportion (2013) centers are those in which radial access had grown to become the predominant access site used for PCI in 2013, whilst high femoral proportion (2013) centers are those in which the femoral artery remained the default access site. This allowed the comparison of three groups of centers with different access site practices in 2013. An alternative stratification was used as a sensitivity analysis, with the femoral proportion in the 12 months preceding operation date (i.e., recent femoral proportion) used to define strata, so that centers may move between strata over time.

Descriptive statistics
	First, we describe the observed associations between center femoral proportion (2013) strata and the changing case-mix and associated outcomes in these strata over time. Patient and procedural characteristics and the outcome of interest, 30-day mortality, were tabulated by center femoral proportion (2013) stratum for their activity in 2007, 2010 and 2013. For categorical variables, multinomial logistic regression was used to determine whether risk-factor changes over time differed across center strata; the dependent variable in this regression model was the risk-factor with center strata and procedure year as the explanatory factors, and we report the p-value from the test of inclusion of an interaction term between strata and year. Analogous tests were performed for continuous variables using multiple linear regression. These analyses were performed across centers stratified by both femoral proportion in 2013 (fixed) and recent femoral proportion (time-dynamic).

Modeling
	Next we aimed to evaluate the association between the exposure of interest, recent femoral proportion, and 30-day mortality, over time and controlling for patient-level and center-level covariates. Using femoral-only procedures, a multiple logistic regression model was developed controlling for covariates that were a-priori selected based on prognostic relevance, availability and data quality: age, sex, indication, cardiogenic shock, intra-aortic balloon-pump support, cardio-pulmonary support, inotropic support, ventilation, left ventricular ejection fraction, MI history, CABG history, stroke history, valvular heart disease, peripheral vascular disease, high cholesterol, hypertension, diabetes status, renal status, smoking status, use of Glycoprotein IIb / IIIa inhibitors (GP IIb/IIIa), concomitant anti-platelet and anti-coagulant strategies, stent type, multi-vessel PCI, left-main stem PCI, procedure date (months since start of study period) and recent total volume. The likelihood ratio test was used to assess the improvement in the goodness of fit when adding both recent femoral proportion and the interaction of recent femoral proportion with recent total volume (equivalent to recent femoral volume) together to this model; significance in this test indicates evidence for association between recent femoral proportion and 30-day mortality after controlling for covariates listed above. In addition to this formal statistical test the association between exposure and outcome was visualized; unadjusted 30-day mortality rates and model-adjusted rates were compared by plotting against recent femoral proportion and against time for each center stratum. Missing data were handled using fully conditional specification multiple imputation with 20 imputed datasets and subsequent model estimates combined using Rubin’s rules.25,26 A ‘multiple imputation, then deletion’ strategy was employed to improve distributional precision of the confounder imputations.27 Information on completeness for each variable over time was also calculated (see Supplementary Table A1).

	As a sensitivity analysis, this analysis was repeated in a clinically non-complex subgroup of patients who were not in shock, not receiving any circulatory support, and not ventilated. An additional sensitivity analysis explored recent femoral proportion effects on center-reported in-hospital vascular complications as an alternative to mortality.

Software
	All data manipulation and analyses were performed using R version 3.2.2. Multiple imputation was implemented using the mice package.
Results
	A total of 246,331 femoral-only procedures across 92 centers in England and Wales in patients aged 18 to 100 inclusive between 1 January 2007 and 31 December 2013 were identified in the BCIS registry. Following exclusions, 235,250 procedures (95·5%) were available for the descriptive analysis and 230,755 (93·7%) available for modeling purposes. Figure 1 summarizes the cohort selection process.

Descriptive
	Changes in procedural volume and access site choice by center over time were studied. Figure 2 depicts center activity and femoral proportion for each center over time, demonstrating that TRA uptake is highly heterogeneous between individual centers. After stratification by each center’s femoral proportion in 2013, there were 53 low (0-33·3%), 23 medium (33·3-66·7%) and 16 high (>66·7%) femoral proportion (2013) centers; these correspond to centers 1-53, 54-76, and 77-92 respectively in Figure 2. Centers that have remained predominantly femoral were more likely to be amongst the lowest volume centers, with 3 in 4 of centers in the high femoral proportion (2013) stratum falling below the median total volume in 2013 (Kruskal-Wallis test for distributional differences in total volume by femoral proportion(2013) strata; p=0.005). 
	Table 1 reports patient and procedural characteristics in the years 2007, 2010 and 2013, stratified by femoral proportion in 2013. Over time, it appears that cases undertaken through the femoral approach were higher risk in those undertaken in predominantly radial centers compared to those undertaken in femoral centers, with a greater prevalence of adverse procedural characteristics such as cardiogenic shock, ventilation, renal failure, previous CABG and ACS presentation. For example, in low femoral proportion (2013) centers (high radial adoption), femoral procedures in patients in cardiogenic shock have increased from 1·7 to 7·9% compared with 1·7 to 3·3% in high femoral proportion (2013) centers (low radial adoption), and these trends were significantly different (p<0·001). Similarly we observed significantly different trends for ventilated patients, with an increase from 0·9 to 5·7% in low femoral proportion (2013) centers compared with 1·4 to 2·4% in high femoral proportion (2013) centers (p<0·001). Supplementary Table A2 replicates Table 1 but stratified by RFP.

Modeling
	The association of recent center femoral experience measures with 30-day mortality in femoral procedures was explored to determine whether centers whose default access site had changed to predominantly radial had worse outcomes than predominantly femoral centers, once case-mix was adjusted for. After case-mix-adjustment, no independent association was observed between 30-day mortality for cases undertaken through the femoral approach and center femoral proportion, the risk-adjusted odds ratio for recent femoral proportion was non-significant (OR=0·99 per 0.1 increase in proportion; CI=0.97 to 1.02; p=0.472), similarly recent femoral volume (recent femoral volume; per 100 procedures) was not found to be significant (OR 1·00 95% CI 0·98 to 1·01; P=0.869). Table 2 describes this model in detail. Figure 3a depicts changes to predicted (and observed) mortality over time by center type, with unadjusted mortality increasing more steeply for centers with low femoral proportion (2013) due to the higher prevalence of high risk cases as illustrated in Table 1; Figure 3b shows the corresponding risk-adjusted mortality with no differences between center type. Figure 4 shows the association between mortality and recent femoral proportion before and after confounder adjustment; there was no residual recent femoral proportion effect after accounting for confounders.

Sensitivity Analysis
	We also performed an analysis of lower risk, less complex cases in whom access route might be considered to be less likely confounded by clinical presentation.  Thus we analyzed the association of recent center femoral experience measures with 30-day mortality in femoral procedures excluding patients who were  in shock,  receiving circulatory support, or were  ventilated (N=169,762). The risk-adjusted odds ratio for recent femoral proportion was non-significant (OR=0.99 per 0·1 increase in proportion; CI=0.95 to 0.02; p=0.461). Supplementary Table A3 describes this model in detail. There are marginal differences in unadjusted mortality changes between center types (Supplementary Figure A1a) but these disappear after risk-adjustment (Supplementary Figure A1b). There was no residual recent femoral proportion effect after accounting for confounders (Supplementary Figure A2).
	Similar models using alternatives to recent femoral proportion as proxies for a center’s femoral experience, such as the odds of access site utilization (recent femoral volume divided by recent radial volume), the number of additional femoral procedures over radial procedures (Recent femoral volume minus recent radial volume), and the number of years since the centre was a majority femoral centre (i.e., years since RFP was last >50%) were also explored with no material effect on the conclusions.
Center type was redefined as the ten lowest femoral proportion centers in 2013 (top ten radial; TRA proportion between 87.1 and 94.8%), the ten highest femoral proportion centers in 2013  (top ten femoral; TFA proportion between 77.8% and 98.4%), and all other centers, so that only the most TRA-committed centers can be compared with those most TFA-committed. These comparisons are displayed in Supplementary Figures A3a and A3b, and are consistent with those observed in Figures 3a and 3b. 






	Adoption of TRA is associated with a reduced risk of mortality in some randomized controlled trials and national registries in high-risk patients undergoing PCI. This has driven a change in UKPCI access site practice, with a transition from a predominantly femoral to a predominantly radial approach in England and Wales over a 7-year period. We demonstrate that this national change in access site practice has not been uniform, with close to 20% of individual PCI centers in England and Wales remaining predominantly femoral in their access site practice (16 out of 92 centers). Our analysis suggests that during this transition period, femoral procedures undertaken in centers that have transitioned to mainly TRA practice are undertaken in increasingly more complex patients, such as those with those with cardiogenic shock, requiring pre PCI ventilation, presenting with an acute coronary syndrome or having had previous CABG. When these complex cases are compared to the simpler cases undertaken in centers that have remained femoral, it is therefore not surprising to see a higher 30-day crude mortality rate in femoral procedures undertaken in the high volume radial centers. However, once differences in case mix are adjusted for, we detect no differences in 30-day mortality or vascular complication rates in PCI cases undertaken through the TFA approach in centers that have transitioned to TRA compared to those centers that have remained predominantly femoral. Thus, we find no evidence of a Campeau radial paradox during this national change in access site practice. In fact, the observed difference in crude unadjusted outcomes appears to be explained entirely by case mix.
	A relationship between operator and center volumes and outcomes has been reported in PCI where increased volume is associated with reduced complications rates and improved clinical outcomes, although such relationships have been observed to be less important in more contemporary literature.14 Similarly, recent work has also focused around whether there is an association between operator and center radial volume with access site related outcomes, ADDIN EN.CITE 5,16,28,29 although most of these were not based upon whether the relationships reported might relate to worse femoral outcomes in the high volume radial operators or centers.18
	The RIVAL study reported that in the subgroup of high volume radial centers the primary outcome was reduced by TRA versus TFA (1.6% vs. 3.2%;HR: 0.49, 95% CI: 0.28 to 0.87) but not in intermediate-(5.4% vs. 4.4%; HR: 1.23, 95% CI: 0.88 to 1.72) or low volume radial centers (3.4% vs. 4.2%; HR: 0.83, 95% CI:0.52 to 1.31; interaction p=0.021). ADDIN EN.CITE 17 Interestingly, when femoral outcomes were studied in the different radial tertiles, no significant differences for the primary outcome for patients randomized to femoral access (high-volume radial centers 3.2% vs. low-volume 4.2% for femoral patients; adjusted HR: 0.67, 95% CI: 0.42 to 1.09;p=0.10) and non-CABG major bleeding (adjusted HR:1.07, 95% CI: 0.41 to 2.79; p=0.89) were observed, ADDIN EN.CITE 16 suggesting that femoral outcomes were not worse in the highest tertile TRA centers. Similarly in a report derived from a high volume default radial center in which TRA access had grown from 31% in 2006 to over 90% in 2010, in-hospital mortality rates (1.10% vs 1.16%), major bleeding rates (1.33% vs 1.14%) and vascular complications (2.07% vs 1.14%) did not significantly increase in patients undergoing TFA over this time period.30 In contrast, in an analysis from the Montreal Heart Institute, access site related outcomes were compared in a historical cohort where only TFA was used (April 1996 to March 1998) and a contemporary cohort (April 2006 to March 2008).  When the center transitioned from TFA to TRA and both approaches were used equally, they found that TFA patients in the contemporary cohort experienced more vascular complications compared with TFA patients in the historical cohort (unadjusted rates: 4.68% vs. 2.89%; p<0.001; adjusted rates: 4.19% vs. 1.98%; adjusted OR: 2.16,95% CI: 1.67 to 2.81; p<0.001). ADDIN EN.CITE 19 This difference was driven by a higher incidence of major hematoma (3.80% vs. 1.24%; p<0.001) and retroperitoneal hematoma (0.22% vs. 0.03%; p=0.002). This analysis was limited by absence of pharmacological data such as glycoprotein IIb/IIIa inhibitor use, anticoagulant use, concomitant femoral vein puncture (23.3% in contemporary cohort) and sheath size in the historical cohort. These issues may have confounded their results.
	Previous work has suggested that patients undergoing femoral procedures in predominantly radial centers tend to be older, more hemodynamically unstable, and have a greater prevalence of adverse procedural risk factors such as renal failure, poor left ventricular function and at higher bleeding risk ADDIN EN.CITE 12,13,31 as defined by the Mehran bleeding risk score. ADDIN EN.CITE 32 Our work shows that nearly 60% of centers in the UK (53 out of 92 centers) have transitioned to become predominantly radial centers with more than two thirds of their PCI case mix being undertaken through the TRA approach. Consistent with the previous studies our analysis confirms that PCI cases undertaken through the TFA approach in these centers in 2013 have a high degree of complexity and are more likely to present with cardiogenic shock (8%), receipt of ventilation (5.7%), and a previous history of CABG (19%) or severe renal disease (5%). It is therefore unsurprising that the unadjusted 30-day mortality rates (6.1%) are significantly greater in 2013 that those reported in centers that have remained predominantly femoral in their practice (2.6%) despite similar mortality rates in 2007 (1.9% vs 1.4%). Once differences in baseline covariates have been adjusted for, femoral 30-day mortality rates have remained similar over time, irrespective of change in access site practice at the individual center level (figure 3b) and neither recent femoral proportion (per 10% increase; OR 0·99 95% CI 0.97-1.02, P=0.47) or femoral volume (per 100 cases; OR 1·00 95% CI 0·98-1·01, P=0.87) are independently associated with increased 30 day mortality risk. Even when TFA outcomes are studied in the top 10 centers where the adoption of TRA has been greatest (Where TRA proportion varies between 87.1 and 94.8% in 2013) and are compared to those recorded in centers that have adopted TRA least (Where TRA proportion varies between 1.6 and 22.2% in 2013) our findings remain consistent.
	Our observations do not identify worse TFA outcomes nationally following transition to a TRA approach and we therefore find no evidence of a Campeau radial paradox. TRA training programs within the UK have contributed to the transition to the TRA as the default access site during PCI. ADDIN EN.CITE 21 This change in access site practice has meant that patients undergoing PCI through the TFA approach are at particularly high risk from access site related complications and major bleeding events because of their adverse clinical characteristics and optimal femoral access site practice, utilizing techniques such as micropuncture techniques, fluoroscopic or ultrasound guidance for femoral access should be considered. In recognition of this, a recent editorial has advocated the importance of maintaining proficiency in basic techniques and monitoring outcomes to ensure optimal TFA access site practice.20 The outcomes gains achieved by the national adoption of radial access ADDIN EN.CITE 21 are not associated with a loss of femoral proficiency and worse outcomes in cases undertaken through a TFA approach in centers that have transitioned to a predominantly radial approach. Centers should be encouraged to continue to adopt radial access as the default access site for PCI wherever possible in line with current best evidence  ADDIN EN.CITE 5,6,33 and current international guidelines. ADDIN EN.CITE 34
	Our study has several limitations. First and foremost, this is an observational study so there remains a risk of unmeasured confounding. Whilst we have used advanced statistical models to investigate outcomes in cases undertaken through the TFA approach, the BCIS dataset does not record measures of co-morbid burden such as Charlson score that have been shown to influence PCI outcomes. ADDIN EN.CITE 35 Secondly, the BCIS dataset does not contain information on crossover between access sites due to failure for cases in which multiple access sites were used, and such cases were excluded from the analysis, although the proportion of such cases in the BCIS dataset is less than 5%. ADDIN EN.CITE 21 Thirdly, missing data is a common problem for observational databases and the BCIS database is no exception. We used multiple imputation approaches, which offer excellent protection against missing completely at random (MCAR) and missing at random (MAR) mechanisms for the data ADDIN EN.CITE 25,36 and managed to include 97.0% of eligible patients in the analyses. However, information for some covariates might be missing not at random (MNAR), thus introducing bias into our estimates, although multiple imputation can still offer some protection in this case. Fourthly, inter-center correlation structures were not considered in our model. There are contemporary methodological inadequacies in dealing jointly with missing data and inter-cluster correlation in regression modelling, so robust center-level random-effects could only be modelled via bootstrapping which involved insurmountable computational costs. Fifthly, our analysis studies outcomes at the center level, as BCIS only has operator identifiable data from 2012 and so cannot provide insight on femoral outcomes at the individual operator level during this period of practice change. Similar limitations are encountered in other analyses that have described a Campeau paradox at the individual center level, where practice at the operator level were not considered. ADDIN EN.CITE 19 Whilst our analysis does not provide insight at the individual operator level whether changes in national practices towards radial have compromised femoral outcomes, our analysis suggests that at the center level changes in access site practice over time towards radial have not compromised femoral outcomes. Finally, whilst we find no evidence of a Campeau paradox in the United Kingdom, our data might not be applicable to other healthcare systems in other countries.
	In conclusion, we have observed significant heterogeneity in the uptake of TRA at the individual center level over time. Once differences in case mix across centers are adjusted for, femoral outcomes are similar between high and low radial proportion centers, with no evidence to suggest that increasing unfamiliarity with the femoral access site practice during the transition to TRA is detrimental. The outcome gains achieved by the national adoption of radial access is not associated with a loss of femoral proficiency, and centers should be encouraged to continue to adopt radial access as the default access site for PCI wherever possible in line with current best evidence.
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